Related Experiment Video
Updated: Dec 14, 2025
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
Published on: June 7, 2015
Precision radiotherapy for non-small cell lung cancer
Wen-Chi Yang1,2, Feng-Ming Hsu3,4, Pan-Chyr Yang5,6
1Division of Radiation Oncology, Department of Oncology, National Taiwan University Hospital, No. 7, Chung-Shan South Rd, Taipei, Taiwan.
Abstract:
Precision medicine is becoming the standard of care in anti-cancer treatment. The personalized precision management of cancer patients highly relies on the improvement of new technology in next generation sequencing and high-throughput big data processing for biological and radiographic information.Systemic precision cancer therapy has been developed for years. However, the role of precision medicine in radiotherapy has not yet been fully implemented. Emerging evidence has shown that precision radiotherapy for cancer patients is possible with recent advances in new radiotherapy technologies, panomics, radiomics and dosiomics.This review focused on the role of precision radiotherapy in non-small cell lung cancer and demonstrated the current landscape.
Insights
Precision medicine is revolutionizing cancer care. Precision radiotherapy, leveraging advances in technology and data analysis, offers new personalized treatment possibilities for non-small cell lung cancer.
Area of Science:
- Oncology
- Radiotherapy
- Genomics
Background:
- Precision medicine is the standard of care in anti-cancer treatment.
- Personalized cancer management relies on next-generation sequencing and big data processing.
- Systemic precision cancer therapy is established, but precision radiotherapy is underutilized.
Purpose of the Study:
- To review the role and current landscape of precision radiotherapy in non-small cell lung cancer.
- To highlight the integration of panomics, radiomics, and dosiomics in precision radiotherapy.
Main Methods:
- Review of emerging evidence and technological advancements in radiotherapy.
- Analysis of panomics, radiomics, and dosiomics data.
- Focus on non-small cell lung cancer applications.
Main Results:
- Precision radiotherapy is feasible with recent technological advances.
- Integration of multi-omics and imaging data enhances treatment personalization.
- Significant potential exists for improving non-small cell lung cancer outcomes.
Conclusions:
- Precision radiotherapy is an emerging frontier in personalized cancer care.
- Further research and implementation are needed to fully realize its potential in non-small cell lung cancer.
- Technological integration is key to advancing precision radiotherapy.
